The Veterinary Medicines Directorate (VMD) announced a new packaging surveillance scheme for veterinary medicines, effective 2 February 2026. Under the scheme, the VMD will select a group of products every three months from wholesalers for packaging assessment. All components of the packaging will be reviewed to confirm they match the approved product information text (QRD) and the Product Literature Standards. Findings will be reported to the Market Authorisation Holder within the assessment period, and where non‑compliance is found, the VMD will specify corrective actions. The scheme also changes mock‑up requirements: from 2 February 2026, mock‑ups are no longer needed for G.I.18 variations requiring assessment or new marketing authorisation procedures. The VMD will still review mock‑ups under G.I.15.z variations, but only for the smallest pack size. Applications already in progress will continue to be assessed as before, and those not yet at the mock‑up phase will be issued without mock‑ups.
© Crown copyright, 2024, GOV.UK.
Summary adapted from content licensed under the Open Government Licence v3.0.
For details, see https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/.
Original source: https://www.gov.uk/
https://www.gov.uk/government/news/launch-of-new-veterinary-medicines-packaging-surveillance-scheme
Made by AI. If you spot anything of concern write us at contact@cybach.com. We’ll promptly correct irregularities.